Center Laboratories, Inc. (TPEX:4123)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
36.50
-1.90 (-4.95%)
Mar 31, 2025, 1:30 PM CST
-16.00%
Market Cap 27.66B
Revenue (ttm) 1.62B
Net Income (ttm) -1.10B
Shares Out 720.42M
EPS (ttm) -1.55
PE Ratio n/a
Forward PE n/a
Dividend 0.75 (1.95%)
Ex-Dividend Date Aug 2, 2024
Volume 2,819,448
Average Volume 841,455
Open 37.80
Previous Close 38.40
Day's Range 36.30 - 37.80
52-Week Range 36.30 - 59.60
Beta 0.78
RSI 25.41
Earnings Date Mar 25, 2025

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising of antipyretic and analgesic, bronchodilator, anti-inflammatory preparations, anti-allergic agent, expectorant, narcotic antitussive and expectorant, gastrointestinal preparations, non-narcotic antitussive and expectorant, and other medicines. It also offers central nervous system medication consisting of cerebrovascular disease, dementia, depressi... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

In 2024, Center Laboratories's revenue was 1.62 billion, an increase of 16.06% compared to the previous year's 1.39 billion. Losses were -1.10 billion, 10.9% more than in 2023.

Financial Statements

News

There is no news available yet.